EcoDrugPlus

Glutamate Metabotropic Receptor 2

Ensembl ID : ENSRFEG00010017440
Gene Symbol: GRM2
1 Cross references
276 Possible Orthologues:

Glutamate Metabotropic Receptor 3

Ensembl ID : ENSRFEG00010020073
Gene Symbol: GRM3
1 Cross references
215 Possible Orthologues:

Glutamate Metabotropic Receptor 4

Ensembl ID : ENSRFEG00010017316
Gene Symbol: GRM4
1 Cross references
272 Possible Orthologues:

Glutamate Metabotropic Receptor 5

Ensembl ID : ENSRFEG00010015430
Gene Symbol: GRM5
1 Cross references
272 Possible Orthologues:

Glutaminase

Ensembl ID : ENSRFEG00010010833
Gene Symbol: GLS
1 Cross references
302 Possible Orthologues:

Glycogen Synthase Kinase 3 Alpha

Ensembl ID : ENSRFEG00010017776
Gene Symbol: GSK3A
1 Cross references
260 Possible Orthologues:

Glycogen Synthase Kinase 3 Beta

Ensembl ID : ENSRFEG00010002338
Gene Symbol: GSK3B
1 Cross references
241 Possible Orthologues:

Gonadotropin Releasing Hormone Receptor

Ensembl ID : ENSRFEG00010013422
Gene Symbol: GNRHR
1 Cross references
454 Possible Orthologues:

Growth Hormone Releasing Hormone Receptor

Ensembl ID : ENSRFEG00010020794
Gene Symbol: GHRHR
1 Cross references
191 Possible Orthologues:

Growth Hormone Secretagogue Receptor

Ensembl ID : ENSRFEG00010000370
Gene Symbol: GHSR
1 Cross references
212 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Alpha 1

Ensembl ID : ENSRFEG00010008788
Gene Symbol: GUCY1A1
1 Cross references
202 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Alpha 2

Ensembl ID : ENSRFEG00010009109
Gene Symbol: GUCY1A2
1 Cross references
202 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).